Evidence map›Paper›PMID 41807551›Full record

ArticleScientific reports2026

Evaluating AI models for food and alcohol advertisement classification against human benchmarks.

Paula-Alexandra Gitu, Roberto Cerina, Alexander Grigoriev, Stefanie Vandevijvere

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Paula-Alexandra GituDepartment of Data Analytics and Digitalization, Maastricht University, Maastricht, 6211 LM, the Netherlands. paula.gitu@maastrichtuniversity.nl.
Roberto CerinaInstitute for Logic, Language and Computation, University of Amsterdam, Amsterdam, 1098 XG, the Netherlands.
Alexander GrigorievDepartment of Data Analytics and Digitalization, Maastricht University, Maastricht, 6211 LM, the Netherlands.
Stefanie VandevijvereEpidemiology and Public Health, Sciensano, Bruxelles, 1050, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growth of food and alcohol marketing on social media creates a need for scalable monitoring methods that go beyond manual processing. This study evaluates whether Large Language Models and Vision-Language Models can recognize advertisements and identify their features in consistence with general public or expert opinion. We collected 1000 Facebook ads from major Belgian brands, and annotated them with 600 crowd workers, three dieticians and four AI models (GPT-4o, Qwen 2.5, Pixtral and Gemma3). Our analysis of the data shows that for single-option advertisement features, like alcohol presence or target group, GPT-4o and Qwen reached agreement with the dietician consensus above 90%, similar to the level of pairwise agreement observed between individual dieticians. Though agreement was lower for multiple choice features, like premium offers and marketing strategies, it was still within the variability observed in crowd raters. The bias analysis revealed how models interpret certain labels, with some being consistently under- or over-detected. Based on these findings, we propose tiered deployment recommendations that distinguish between ad features that MLLMs can already monitor with human-level accuracy, and more complex features requiring expert oversight and taxonomy refinement, like marketing strategies or food categories.

Indexed as

AdvertisingAlcoholic BeveragesArtificial IntelligenceFoodBenchmarkingHumansLarge Language ModelsMarketingSocial Media

Identifiers

PMID41807551
PMCPMC13099998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.